Patient presents with progressive cognitive decline consistent with a diagnosis of Senile Dementia, also known as Alzheimer's Disease or Major Neurocognitive Disorder due to Alzheimer's Disease.  Symptoms include gradual memory loss, particularly affecting recent events, impacting activities of daily living.  The patient exhibits impaired judgment, confusion, disorientation, and difficulty with language, including word-finding difficulties and aphasia.  Behavioral changes such as apathy, social withdrawal, personality changes, and agitation are also noted.  The patient's Mini-Mental State Examination (MMSE) score indicates significant cognitive impairment.  Differential diagnoses considered include vascular dementia, Lewy body dementia, and frontotemporal dementia.  Neurological examination reveals no focal deficits.  Brain imaging, such as MRI or CT scan, may be ordered to rule out other potential causes and evaluate for characteristic Alzheimer's Disease changes, such as atrophy.  Current medications include Donepezil for cognitive symptoms.  Caregiver support and education regarding disease progression, management strategies, and available resources are provided.  The patient and family are advised on safety precautions to mitigate fall risks and wandering behavior.  Follow-up appointments are scheduled for monitoring of disease progression and medication management, including potential adjustments to Cholinesterase inhibitors or Memantine.  ICD-10 code G30.9, Alzheimer's disease, unspecified, is used for billing and coding purposes.  CPT codes for evaluation and management services will be used based on the complexity of the visit. The prognosis for Senile Dementia is generally progressive decline.  Focus is placed on optimizing quality of life, managing symptoms, and providing comprehensive support to both the patient and their caregivers.